Familiar Dermatologic Drugs as Therapies for COVID-19

被引:2
作者
Ortega-Pena, M. [1 ]
Gonzalez-Cuevas, R. [2 ]
机构
[1] Univ Mayor, Escuela Med, Santiago, Chile
[2] Hosp Salvador, Serv Dermatol, Santiago, Chile
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2021年 / 112卷 / 02期
关键词
Severe acute respiratory syndrome; Coronavirus; Antimalarials; chloroquine; Hydroxychloroquine; Ivermectin; Melatonin; POTENT ANTHELMINTIC AGENTS; OXIDATIVE STRESS; MELATONIN; CHLOROQUINE; AVERMECTINS; SARS-COV-2; HISTORY; HYDROXYCHLOROQUINE; IVERMECTIN; MALARIA;
D O I
10.1016/j.ad.2020.09.004
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandrogenic agents, melatonin, and the antimalarial drugs chloroquine and hydroxychloroquine. These and other agents, some of which have proven controversial, are being scrutinized by the scientific community. We briefly review the aforementioned dermatologic drugs and describe the most recent findings relevant to their use against COVID-19. (C) 2020 AEDV. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:118 / 126
页数:9
相关论文
共 92 条
[1]   Ebola Virus: Melatonin as a Readily Available Treatment Option [J].
Anderson, George ;
Maes, Michael ;
Markus, Regina P. ;
Rodriguez, Moses .
JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (04) :537-543
[2]  
[Anonymous], 2017, CELL MOL LIFE SCI, DOI DOI 10.1007/s00018-017-2609-7
[3]   Aaron Lerner, who discovered melatonin - Obituary [J].
Arendt, Josephine .
JOURNAL OF PINEAL RESEARCH, 2007, 43 (01) :106-107
[4]   Aaron Lerner: Perspectives and lessons learned from the melatonin days - In memoriam [J].
Barchas, Jack D. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (09) :2085-2089
[5]   The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial [J].
Bazyar, Hadi ;
Gholinezhad, Hassan ;
Moradi, Leila ;
Salehi, Parvin ;
Abadi, Faezeh ;
Ravanbakhsh, Maryam ;
Javid, Ahmad Zare .
INFLAMMOPHARMACOLOGY, 2019, 27 (01) :67-76
[6]   PROTECTIVE EFFECTS OF MELATONIN IN MICE INFECTED WITH ENCEPHALITIS VIRUSES [J].
BENNATHAN, D ;
MAESTRONI, GJM ;
LUSTIG, S ;
CONTI, A .
ARCHIVES OF VIROLOGY, 1995, 140 (02) :223-230
[7]   TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium [J].
Bertram, Stephanie ;
Dijkman, Ronald ;
Habjan, Matthias ;
Heurich, Adeline ;
Gierer, Stefanie ;
Glowacka, Ilona ;
Welsch, Kathrin ;
Winkler, Michael ;
Schneider, Heike ;
Hofmann-Winkler, Heike ;
Thiel, Volker ;
Poehlmann, Stefan .
JOURNAL OF VIROLOGY, 2013, 87 (11) :6150-6160
[8]   Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus [J].
Bonilla, E ;
ValeroFuenmayor, N ;
Pons, H ;
ChacinBonilla, L .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1997, 53 (05) :430-434
[9]  
Burba J., 2018, CINCHONA BARK
[10]   AVERMECTINS, NEW FAMILY OF POTENT ANTHELMINTIC AGENTS - PRODUCING ORGANISM AND FERMENTATION [J].
BURG, RW ;
MILLER, BM ;
BAKER, EE ;
BIRNBAUM, J ;
CURRIE, SA ;
HARTMAN, R ;
KONG, YL ;
MONAGHAN, RL ;
OLSON, G ;
PUTTER, I ;
TUNAC, JB ;
WALLICK, H ;
STAPLEY, EO ;
OIWA, R ;
OMURA, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (03) :361-367